$WINV
WinVest Acquisition Corp

2024 Q3 Form 10-Q Financial Statement

#000149315224031674 Filed on August 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $946.5K $553.2K
YoY Change 267.59% -14.88%
Operating Profit -$946.5K -$553.2K
YoY Change 267.59% -14.88%
Interest Expense $142.0K
YoY Change -38.28%
% of Operating Profit
Other Income/Expense, Net $73.75K $142.0K
YoY Change -56.06% -38.1%
Pretax Income -$872.7K -$411.2K
YoY Change 873.63% -2.21%
Income Tax $11.00K $29.00K
% Of Pretax Income
Net Earnings -$883.7K -$440.2K
YoY Change 752.72% -3.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$0.12
COMMON SHARES
Basic Shares Outstanding 3.367M shares 4.018M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $480.00
YoY Change
Cash & Equivalents $548.00 $477.00
Short-Term Investments
Other Short-Term Assets $169.7K
YoY Change -15.15%
Inventory
Prepaid Expenses $93.45K $169.7K
Receivables
Other Receivables
Total Short-Term Assets $94.00K $170.2K
YoY Change 17.67% -25.21%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $5.630M
YoY Change -58.91%
Other Assets
YoY Change
Total Long-Term Assets $5.794M $5.630M
YoY Change -58.71% -58.81%
TOTAL ASSETS
Total Short-Term Assets $94.00K $170.2K
Total Long-Term Assets $5.794M $5.630M
Total Assets $5.888M $5.800M
YoY Change -58.28% -58.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.496M
YoY Change 24.7%
Accrued Expenses $154.1K
YoY Change 54.12%
Deferred Revenue
YoY Change
Short-Term Debt $2.279M
YoY Change 153.19%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.023M $4.051M
YoY Change 75.76% 59.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $4.025M
YoY Change 0.63%
Total Long-Term Liabilities $4.025M
YoY Change 0.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.023M $4.051M
Total Long-Term Liabilities $4.025M
Total Liabilities $9.048M $8.076M
YoY Change 31.46% 23.04%
SHAREHOLDERS EQUITY
Retained Earnings -$8.954M -$7.906M
YoY Change 31.62% 24.77%
Common Stock $288.00 $288.00
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$8.954M -$7.906M
YoY Change
Total Liabilities & Shareholders Equity $5.888M $5.800M
YoY Change -58.28% -58.26%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$883.7K -$440.2K
YoY Change 752.72% -3.99%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$449.8K
YoY Change 104.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $7.227M
YoY Change 10.0%
Cash From Investing Activities $7.227M
YoY Change 10.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.827M
YoY Change 6.51%
NET CHANGE
Cash From Operating Activities -449.8K
Cash From Investing Activities 7.227M
Cash From Financing Activities -6.827M
Net Change In Cash -49.64K
YoY Change -17.27%
FREE CASH FLOW
Cash From Operating Activities -$449.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-458516 usd
us-gaap Net Income Loss
NetIncomeLoss
-546653 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_849_eus-gaap--UseOfEstimates_zpKiUrn1Vjed" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_z8K7HyKGgLEl">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
usd
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
492333 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
1143123 shares
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
5629889 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12453412 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
492333 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
1143123 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
288 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
288 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7906357 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6742352 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-7906069 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6742064 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5800062 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12724289 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
553160 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
649848 usd
us-gaap Operating Expenses
OperatingExpenses
778261 usd
us-gaap Operating Expenses
OperatingExpenses
1219426 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-553160 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-649848 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-778261 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1219426 usd
CY2024Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
141953 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
229332 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
284608 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
438383 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
141953 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
229332 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
284608 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
438383 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-411207 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-420516 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-493653 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-781043 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29000 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
53000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
82000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-440207 usd
us-gaap Net Income Loss
NetIncomeLoss
-863043 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4587849 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
434200 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-404527 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-5426576 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
383961 usd
CY2023Q2 WINV Stock Issued During Period Value Excise Tax Payable
StockIssuedDuringPeriodValueExciseTaxPayable
-67218 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-458516 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-6336271 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-6742064 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
262269 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-106446 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7110779 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-7110779 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
281411 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-440207 usd
CY2024Q2 WINV Stock Issued During Period Value Excise Tax Payable
StockIssuedDuringPeriodValueExciseTaxPayable
-73672 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-7906069 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-7906069 usd
us-gaap Net Income Loss
NetIncomeLoss
-546653 usd
us-gaap Net Income Loss
NetIncomeLoss
-863043 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
278730 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
438013 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-99814 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
36579 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-51901 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
219429 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
589731 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
-67000 usd
us-gaap Increase Decrease In Property And Other Taxes Payable
IncreaseDecreaseInPropertyAndOtherTaxesPayable
82000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
60000 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
58000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-549719 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-519424 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
305000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
690000 usd
WINV Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes
ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes
40050 usd
WINV Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes
ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes
309851 usd
WINV Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
7367204 usd
WINV Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
6721795 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
7102254 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
6341646 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
472200 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
123000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
305000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
690000 usd
WINV Proceed For Redemption Of Common Stock
ProceedForRedemptionOfCommonStock
7367204 usd
WINV Proceed For Redemption Of Common Stock
ProceedForRedemptionOfCommonStock
6721795 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6590004 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5908795 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-37469 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-86573 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37946 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
88247 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
477 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1674 usd
WINV Accretion Of Common Stock Subject To Redemption
AccretionOfCommonStockSubjectToRedemption
543680 usd
WINV Accretion Of Common Stock Subject To Redemption
AccretionOfCommonStockSubjectToRedemption
818161 usd
WINV Excise Tax Payable
ExciseTaxPayable
73672 usd
WINV Excise Tax Payable
ExciseTaxPayable
67218 usd
CY2021Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10000000 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000000 usd
us-gaap Debt Instrument Redemption Price Percentage
DebtInstrumentRedemptionPricePercentage
1 pure
WINV Investment Of Cash In Trust Account
InvestmentOfCashInTrustAccount
125000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
5000001 usd
CY2024Q2 WINV Extension Note Related Party
ExtensionNoteRelatedParty
1500000 usd
CY2023Q4 WINV Extension Note Related Party
ExtensionNoteRelatedParty
1195000 usd
us-gaap Interest Paid Net
InterestPaidNet
100000 usd
WINV Percentage Of Deferred Underwriting Discounts And Commissions Payable To Underwriters
PercentageOfDeferredUnderwritingDiscountsAndCommissionsPayableToUnderwriters
0.035 pure
us-gaap Interest Paid Net
InterestPaidNet
100000 usd
CY2022Q3 WINV Effective Tax Description
EffectiveTaxDescription
a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase.
CY2023Q2 WINV Redemption Of Common Stock
RedemptionOfCommonStock
6721795 usd
CY2024Q2 WINV Redemption Of Common Stock
RedemptionOfCommonStock
7367204 usd
CY2024Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
154115 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
80443 usd
CY2024Q2 WINV Excise Tax Liability Percentage
ExciseTaxLiabilityPercentage
0.01 pure
CY2023Q4 WINV Excise Tax Liability Percentage
ExciseTaxLiabilityPercentage
0.01 pure
CY2024Q1 WINV Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes
ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes
40050 usd
CY2023Q1 WINV Proceeds From Withdrawal Of Interest From Trust Account To Pay Taxes
ProceedsFromWithdrawalOfInterestFromTrustAccountToPayTaxes
104305 usd
CY2024Q1 us-gaap Other General Expense
OtherGeneralExpense
90000 usd
CY2024Q1 WINV Working Capital Loan
WorkingCapitalLoan
90000 usd
CY2024Q2 us-gaap Cash
Cash
477 usd
CY2024Q2 WINV Working Capital
WorkingCapital
-3881069 usd
us-gaap Net Income Loss
NetIncomeLoss
-546653 usd
us-gaap Operating Expenses
OperatingExpenses
778261 usd
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
116150000 usd
CY2024Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.071 pure
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.090 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.107 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.105 pure
CY2024Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zBce9eTI6mFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_868_zx9lR9ooqxZ7">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in financial institutions, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90F_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zZyHCYCt3I42" title="Cash FDIC">250,000</span>. As of June 30, 2024, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
5629889 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
12453412 usd
WINV Redemption Description
RedemptionDescription
Subsequent to calculating the total loss allocable to both sets of shares, the Company split the amount to be allocated using a ratio of 0% for the redeemable Public Shares and 100% for the non-redeemable shares, reflective of the respective participation rights, for the three and six months ended June 30, 2024.
WINV Change In Value Of Common Stock Subject To Possible Redemption Shares
ChangeInValueOfCommonStockSubjectToPossibleRedemptionShares
11966667 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2024Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
2923969 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
2400000 usd
CY2024Q2 WINV Deferred Underwriting Commissions
DeferredUnderwritingCommissions
4025000 usd
us-gaap Professional Fees
ProfessionalFees
10000 usd
CY2022Q3 us-gaap Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Rate
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationRate
0.01 pure
CY2022Q3 WINV Percentage Of Aggregate Sales Price Of Securities Sold
PercentageOfAggregateSalesPriceOfSecuritiesSold
0.05 pure
CY2024Q2 WINV Deferred Underwriting Commissions
DeferredUnderwritingCommissions
4025000 usd
CY2023Q4 WINV Deferred Underwriting Commissions
DeferredUnderwritingCommissions
4025000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
19571562 usd
CY2023 WINV Deposits To Trust Account
DepositsToTrustAccount
1070000 usd
CY2023 WINV Temporary Equity Remeasurement Value Adjustment Subject To Possible Redemption
TemporaryEquityRemeasurementValueAdjustmentSubjectToPossibleRedemption
755103 usd
CY2023 WINV Stock Issued During Period Value Taxes Withdrawn From Trust Account
StockIssuedDuringPeriodValueTaxesWithdrawnFromTrustAccount
898940 usd
CY2023 WINV Redemption Of Common Stock
RedemptionOfCommonStock
8044313 usd
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
12453412 usd
WINV Deposits To Trust Account
DepositsToTrustAccount
305000 usd
WINV Redemption Of Common Stock
RedemptionOfCommonStock
7367204 usd
WINV Stock Issued During Period Value Taxes Withdrawn From Trust Account
StockIssuedDuringPeriodValueTaxesWithdrawnFromTrustAccount
40050 usd
WINV Temporary Equity Remeasurement Value Adjustment Subject To Possible Redemption
TemporaryEquityRemeasurementValueAdjustmentSubjectToPossibleRedemption
278731 usd
CY2024Q2 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
5629889 usd
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
11.50

Files In Submission

Name View Source Status
0001493152-24-031674-index-headers.html Edgar Link pending
0001493152-24-031674-index.html Edgar Link pending
0001493152-24-031674.txt Edgar Link pending
0001493152-24-031674-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
winv-20240630.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
winv-20240630_cal.xml Edgar Link unprocessable
winv-20240630_def.xml Edgar Link unprocessable
winv-20240630_lab.xml Edgar Link unprocessable
winv-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed